D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 55,191 234 World Ranking 7427 National Ranking 4030

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

The scientist’s investigation covers issues in Thyroid cancer, Internal medicine, Thyroid, Thyroid carcinoma and Endocrinology. The concepts of his Thyroid cancer study are interwoven with issues in Surgery, Survival analysis and Carcinoma. His Internal medicine research includes elements of Gastroenterology and Oncology.

His Thyroid research is multidisciplinary, incorporating perspectives in Hormone and Nuclear medicine. His studies in Endocrinology integrate themes in fields like Heart disease and Dilated cardiomyopathy. His research integrates issues of Fine-needle aspiration, Biopsy, Radiology and General surgery in his study of Thyroid nodules.

His most cited work include:

  • Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (7026 citations)
  • 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. (5016 citations)
  • Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. (1764 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Thyroid cancer, Oncology, Thyroid carcinoma and Thyroid are his primary areas of study. His research is interdisciplinary, bridging the disciplines of Endocrinology and Internal medicine. His Thyroid cancer study combines topics in areas such as Carcinoma, Clinical trial, Pathology and Surgery, Refractory.

His study looks at the relationship between Oncology and topics such as Radioactive iodine, which overlap with Locally advanced. His research in Thyroid carcinoma intersects with topics in Medullary cavity and Cancer research. Steven I. Sherman has included themes like Hormone, Nuclear medicine and General surgery in his Thyroid study.

He most often published in these fields:

  • Internal medicine (62.55%)
  • Thyroid cancer (50.19%)
  • Oncology (38.20%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (62.55%)
  • Thyroid cancer (50.19%)
  • Oncology (38.20%)

In recent papers he was focusing on the following fields of study:

Steven I. Sherman mainly focuses on Internal medicine, Thyroid cancer, Oncology, Cancer and Cancer research. In his study, Liquid biopsy and Retrospective cohort study is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine. His Thyroid cancer study is concerned with Thyroid in general.

His Oncology research is multidisciplinary, incorporating elements of Targeted therapy, Anaplastic thyroid cancer, Disease and Refractory. His Cancer study combines topics from a wide range of disciplines, such as Large population and KRAS, Neuroblastoma RAS viral oncogene homolog. His work deals with themes such as Medullary cavity, Radiation therapy and Thyroid nodules, which intersect with Thyroid carcinoma.

Between 2015 and 2021, his most popular works were:

  • American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (151 citations)
  • Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial (139 citations)
  • A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (125 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

His primary scientific interests are in Internal medicine, Cancer, Carcinoma, Thyroid cancer and Endocrinology. As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, KRAS and Biomarker. His Cancer research incorporates elements of Surgical oncology, Intensive care medicine, Endocrine surgery and Endocrine system.

His work focuses on many connections between Carcinoma and other disciplines, such as Thyroid carcinoma, that overlap with his field of interest in Thyroid nodules, Adenocarcinoma and Radiation therapy. His Thyroid cancer study results in a more complete grasp of Thyroid. His biological study spans a wide range of topics, including Medullary cavity and Radiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos.
Thyroid (2009)

12876 Citations

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Bryan R. Haugen;Erik K. Alexander;Keith C. Bible;Gerard M. Doherty.
Thyroid (2009)

8718 Citations

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos.
Thyroid (2006)

2808 Citations

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally.
Cell (2014)

1857 Citations

Management of thyroid nodules detected at US: Society of radiologists in ultrasound consensus conference statement

Mary C. Frates;Carol B. Benson;J. William Charboneau;Edmund S. Cibas.
Radiology (2005)

1677 Citations

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

Martin Schlumberger;Makoto Tahara;Lori J. Wirth;Bruce Robinson.
The New England Journal of Medicine (2015)

1186 Citations

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

Marcia S Brose;Christopher M Nutting;Barbara Jarzab;Rossella Elisei.
The Lancet (2014)

1019 Citations

Cabozantinib in Progressive Medullary Thyroid Cancer

Rossella Elisei;Martin J. Schlumberger;Stefan P. Müller;Patrick Schöffski.
Journal of Clinical Oncology (2013)

815 Citations

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

Ernest L. Mazzaferri;R. J. Robbins;C. A. Spencer;L. E. Braverman.
The Journal of Clinical Endocrinology and Metabolism (2003)

804 Citations

A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

Bryan R. Haugen;Furio Pacini;Christoph Reiners;Martin Schlumberger.
The Journal of Clinical Endocrinology and Metabolism (1999)

747 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Steven I. Sherman

R. Michael Tuttle

R. Michael Tuttle

Memorial Sloan Kettering Cancer Center

Publications: 160

Eun-Kyung Kim

Eun-Kyung Kim

Yonsei University

Publications: 139

Martin Schlumberger

Martin Schlumberger

Institut Gustave Roussy

Publications: 138

Ashok R. Shaha

Ashok R. Shaha

Memorial Sloan Kettering Cancer Center

Publications: 134

Rossella Elisei

Rossella Elisei

University of Pisa

Publications: 123

Julie A. Sosa

Julie A. Sosa

University of California, San Francisco

Publications: 119

Furio Pacini

Furio Pacini

University of Siena

Publications: 111

Yuri E. Nikiforov

Yuri E. Nikiforov

University of Pittsburgh

Publications: 94

Sophie Leboulleux

Sophie Leboulleux

Institut Gustave Roussy

Publications: 89

Sebastiano Filetti

Sebastiano Filetti

Sapienza University of Rome

Publications: 81

Akira Miyauchi

Akira Miyauchi

Tokai University

Publications: 76

Fulvio Basolo

Fulvio Basolo

University of Pisa

Publications: 75

Zubair W. Baloch

Zubair W. Baloch

Hospital of the University of Pennsylvania

Publications: 71

Ronald Ghossein

Ronald Ghossein

Memorial Sloan Kettering Cancer Center

Publications: 70

Kenneth D. Burman

Kenneth D. Burman

MedStar Washington Hospital Center

Publications: 68

Herbert Chen

Herbert Chen

University of Alabama at Birmingham

Publications: 65

Trending Scientists

Mahmoud Naghshineh

Mahmoud Naghshineh

IBM (United States)

Eileen Scanlon

Eileen Scanlon

The Open University

Otmar Hilliges

Otmar Hilliges

ETH Zurich

Song-Charng Kong

Song-Charng Kong

Iowa State University

Dirk Thierens

Dirk Thierens

Utrecht University

Yonghao Zhao

Yonghao Zhao

Nanjing University of Science and Technology

Vitali F. Nesterenko

Vitali F. Nesterenko

University of California, San Diego

Luiz Carlos Gomes

Luiz Carlos Gomes

State University of Maringa

Allan J. Clarke

Allan J. Clarke

Florida State University

Jianmin Ma

Jianmin Ma

Peking University

Lucia Regolin

Lucia Regolin

University of Padua

Vicente E. Torres

Vicente E. Torres

Mayo Clinic

Patrick M. Catalano

Patrick M. Catalano

Case Western Reserve University

Michael J. Edwards

Michael J. Edwards

University of Cincinnati

Karl Atkin

Karl Atkin

University of York

Pekka Virtanen

Pekka Virtanen

Tampere University

Something went wrong. Please try again later.